Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
9.15B
Market cap9.15B
Price-Earnings ratio
26.70
Price-Earnings ratio26.70
Dividend yield
Dividend yield
Average volume
2.02M
Average volume2.02M
High today
$135.58
High today$135.58
Low today
$131.24
Low today$131.24
Open price
$135.40
Open price$135.40
Volume
1.74M
Volume1.74M
52 Week high
$354.88
52 Week high$354.88
52 Week low
$126.40
52 Week low$126.40

Stock Snapshot

The current Insulet(PODD) stock price is $131.96, with a market capitalization of 9.15B. The stock trades at a price-to-earnings (P/E) ratio of 26.70.

On 2026-09-12, Insulet(PODD) stock traded between a low of $131.24 and a high of $135.58. Shares are currently priced at $131.96, which is +0.5% above the low and -2.7% below the high.

The Insulet(PODD)'s current trading volume is 1.74M, compared to an average daily volume of 2.02M.

During the past year, Insulet(PODD) stock moved between $126.40 at its lowest and $354.88 at its peak.

During the past year, Insulet(PODD) stock moved between $126.40 at its lowest and $354.88 at its peak.

PODD News

MarketWatch 16h
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch

...

Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
TipRanks 2d
Insulet announces upcoming director resignations amid transitions

The latest update is out from Insulet ( (PODD) ). On September 3, 2026, longtime director and former chairman Timothy J. Scannell stepped down from Insulet’s b...

Simply Wall St 6d
Should Insulet’s Strong Quarter but Cautious Outlook Require Action From Insulet Investors?

In the past quarter, Insulet reported a strong second-quarter update, beating earnings and revenue estimates on solid Omnipod demand while pairing this with mor...

Should Insulet’s Strong Quarter but Cautious Outlook Require Action From Insulet Investors?

Analyst ratings

57%

of 28 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.